These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16533890)

  • 1. Are hemostasis and thrombosis two sides of the same coin?
    Colman RW
    J Exp Med; 2006 Mar; 203(3):493-5. PubMed ID: 16533890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis.
    Kleinschnitz C; Stoll G; Bendszus M; Schuh K; Pauer HU; Burfeind P; Renné C; Gailani D; Nieswandt B; Renné T
    J Exp Med; 2006 Mar; 203(3):513-8. PubMed ID: 16533887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XI and XII as antithrombotic targets.
    Müller F; Gailani D; Renné T
    Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrinsic pathway of coagulation and arterial thrombosis.
    Gailani D; Renné T
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological regulation of factor XII activation may be a new target to control pathological coagulation.
    Schousboe I
    Biochem Pharmacol; 2008 Mar; 75(5):1007-13. PubMed ID: 17996217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The intrinsic pathway of coagulation is essential for thrombus stability in mice.
    Renné T; Nieswandt B; Gailani D
    Blood Cells Mol Dis; 2006; 36(2):148-51. PubMed ID: 16466946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective thrombus formation in mice lacking coagulation factor XII.
    Renné T; Pozgajová M; Grüner S; Schuh K; Pauer HU; Burfeind P; Gailani D; Nieswandt B
    J Exp Med; 2005 Jul; 202(2):271-81. PubMed ID: 16009717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XII inhibition reduces thrombus formation in a primate thrombosis model.
    Matafonov A; Leung PY; Gailani AE; Grach SL; Puy C; Cheng Q; Sun MF; McCarty OJ; Tucker EI; Kataoka H; Renné T; Morrissey JH; Gruber A; Gailani D
    Blood; 2014 Mar; 123(11):1739-46. PubMed ID: 24408325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis.
    Stavrou E; Schmaier AH
    Thromb Res; 2010 Mar; 125(3):210-5. PubMed ID: 20022081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood coagulation factor XII--a neglected player in stroke pathophysiology.
    Pham M; Stoll G; Nieswandt B; Bendszus M; Kleinschnitz C
    J Mol Med (Berl); 2012 Feb; 90(2):119-26. PubMed ID: 21909687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Factor XII in hemostasis and thrombosis: clinical implications.
    Renné T; Gailani D
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):733-41. PubMed ID: 17605651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
    Müller F; Renné T
    Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo roles of factor XII.
    Renné T; Schmaier AH; Nickel KF; Blombäck M; Maas C
    Blood; 2012 Nov; 120(22):4296-303. PubMed ID: 22993391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
    Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T; Castellino FJ
    Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.
    Revenko AS; Gao D; Crosby JR; Bhattacharjee G; Zhao C; May C; Gailani D; Monia BP; MacLeod AR
    Blood; 2011 Nov; 118(19):5302-11. PubMed ID: 21821705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of liver-derived factor XII by GalNAc-siRNA ALN-F12 prevents thrombosis in mice without impacting hemostatic function.
    Liu J; Cooley BC; Akinc A; Butler J; Borodovsky A
    Thromb Res; 2020 Dec; 196():200-205. PubMed ID: 32896690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
    Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
    Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The hemostatic role of factor XI.
    Puy C; Rigg RA; McCarty OJ
    Thromb Res; 2016 May; 141 Suppl 2(Suppl 2):S8-S11. PubMed ID: 27207433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor XI and factor XII as targets for new anticoagulants.
    Weitz JI
    Thromb Res; 2016 May; 141 Suppl 2():S40-5. PubMed ID: 27207423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.